Sign up
Pharma Capital
EPIC: 1AD
Market: ASX
52-week High/Low: A$0.40 / A$0.21
Sector: Pharma & Biotech
Market Cap: A$24.70M
Website: adalta.com.au

AdAlta Limited (ASX:1AD) is using its technology platform to generate a promising new class of protein therapeutics.

Adalta Ltd

adalta.com.au

Interactive graph

col 3
col 4
col 5
col 6

Adalta Ltd Snapshot

View full 1AD profile View Profile
View All

Executive video interviews

VIEW ALL VIDEOS

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.